Skip to content


BMC Cancer

Open Access

Erratum to: BiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational study

  • Mauricette Michallet1Email author,
  • Elisabeth Luporsi2,
  • Pierre Soubeyran3,
  • Nadia Ali Amar4,
  • Vincent Boulanger5,
  • Miguel Carreiro6,
  • Louis-Marie Dourthe7,
  • Jean-Luc Labourey5, 8,
  • Daniel Lepille9,
  • Frédéric Maloisel7,
  • Jean-Loup Mouysset10,
  • Sophie Nahon11,
  • Bérengère Narciso12,
  • Pierre Nouyrigat13,
  • Raouf Radji14,
  • Nacéra Sakek15,
  • Hélène Albrand16 and
  • The ORHEO study group
BMC Cancer201414:720

Received: 3 September 2014

Accepted: 18 September 2014

Published: 26 September 2014

The original article was published in BMC Cancer 2014 14:503


After publication of this Research Article [1], we noted errors in Table 1, and in the rate of thromboembolic events (page 7). Specifically, in Table 1 the percentage of female and male patients were incorrectly given as 7% and 3% respectively. The correct figures are 48.6% female and 51.4% male (please see a corrected version of Table 1 below, and the Additional file 1). The correct rate of thromboembolic events is 3.49% (originally stated as 3.55%).
Table 1

Patient demographics



Age, mean ± SD (years)

66.49 ± 11.77

Patients with solid tumours, mean (years)


Patients with lymphoma, mean (years)


Patients with myeloma, mean (years)


Female (%)


Male (%)


Hb, mean ± SD (g/dL)

9.59 ± 0.88

sBP, mean ± SD (mmHg)

125.75 ± 14.48

dBP, mean ± SD (mmHg)

74.18 ± 9.79

Malignancies, n (%)

2310 (100)

Solid tumours, n (%)

1838 (79.57)

Lymphoma, n (%)

301 (13.03)

Myeloma, n (%)

171 (7.40)

Height, mean ± SD (cm)

166.35 ± 8.72

Weight, mean ± SD (kg)

67.46 ± 14.23

BMI, mean ± SD (kg/m2)

24.33 ± 4.62

BMI body mass index, dBP diastolic blood pressure, Hb haemoglobin, sBP systolic blood pressure, SD standard deviation.



Authors’ Affiliations

Centre Hospitalier Lyon Sud, Lyon, France
Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France
Institut Bergonie, Bordeaux, France
Centre Hospitalier de Troyes, Troyes, France
Centre Hospitalier de Carcassonne, Carcassonne, France
Centre Hospitalier de Montauban, Montauban, France
Clinique Sainte Anne, Strasbourg, France
Polyclinique Montréal, Carcassonne, France
Clinique Pasteur, Evreux, France
Clinique Rambot-Provencale, Aix en Provence, France
Centre Hospitalier d’Aix en Provence, Aix en Provence, France
Centre Hospitalier Régional Universitaire de Tours, Tours, France
Clinique du Cap d’Or, La Seyne sur Mer, France
Centre Frédéric JOLLIOT, Rouen, France
Centre Hospitalier de Montbéliard, Montbeliard, France
Laboratoire HOSPIRA France, MeudonLa Foret, France


  1. Michallet M, Luporsi E, Soubeyran P, Amar NA, Boulanger V, Carreiro M, Dourthe L-M, Labourey J-L, Lepille D, Maloisel F, Mouysset J-L, Nahon S, Narciso B, Nouyrigat P, Radji R, Sakek N, Albrand H: BiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational study. BMC Cancer. 2014, 14: 503-10.1186/1471-2407-14-503.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:


© Michallet et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.